Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
JP Stock MarketDetailed Quotes
Takeda Pharmaceutical (4502)
- 5073.0
- -103.0-1.99%
20min DelayMarket Closed Jan 16 15:30 JST
8.07TMarket Cap75.46P/E (Static)
5122.0High5034.0Low4.99MVolume5101.0Open5176.0Prev Close25.29BTurnover5230.052wk High0.33%Turnover Ratio1.59BShares3916.052wk Low20.57EPS TTM7.76TFloat Cap8080.0Historical High75.46P/E (Static)1.53BShs Float2894.5Historical Low67.23EPS LYR1.70%Range %198.00Dividend TTM1.12P/B100Lot Size3.90%Div Yield TTM
Takeda Pharmaceutical (4502) Income Statement
Quarterly+Annual
YOY
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -5.38%1.11T | -8.39%1.11T | 7.45%4.58T | 0.24%1.05T | 2.96%1.14T | 12.75%1.18T | 14.11%1.21T | 5.87%4.26T | 9.91%1.05T | 1.33%1.11T |
| Operating revenue | -5.38%1.11T | -8.39%1.11T | 7.45%4.58T | 0.24%1.05T | 2.96%1.14T | 12.75%1.18T | 14.11%1.21T | 5.87%4.26T | 9.91%1.05T | 1.33%1.11T |
| Cost of revenue | -3.61%380.06B | -0.59%384.68B | 10.76%1.58T | -0.11%382.08B | 9.85%416.87B | 14.76%394.31B | 20.50%386.95B | 14.68%1.43T | 23.48%382.5B | 12.95%379.48B |
| Gross profit | -6.27%732.74B | -12.06%722.01B | 5.79%3T | 0.44%671.32B | -0.61%727.25B | 11.75%781.73B | 11.33%821.04B | 1.93%2.84T | 3.40%668.37B | -3.80%731.71B |
| Operating expense | 11.09%663.74B | -17.91%537.45B | 1.80%2.52T | 14.52%602.78B | -16.71%660.31B | -20.21%597.48B | 15.08%654.71B | 12.54%2.47T | 14.30%526.35B | 29.21%792.79B |
| Selling and administrative expenses | -5.49%253.55B | -5.24%255.89B | 4.83%1.1T | 3.73%295.87B | 1.15%270.59B | 6.06%268.28B | 8.83%270.03B | 5.67%1.05T | 11.95%285.23B | 1.99%267.52B |
| Research and development costs | -8.02%161.48B | -14.59%143.89B | 0.04%730.23B | 10.29%216.01B | -9.17%170.19B | -4.56%175.56B | 3.52%168.46B | 15.25%729.92B | 21.69%195.86B | 7.30%187.38B |
| Depreciation amortization depletion | 44.06%205.16B | -19.16%131.64B | -1.36%643.23B | 39.94%203.08B | -46.69%134.91B | -40.72%142.41B | 25.81%162.83B | 20.22%652.12B | 8.92%145.11B | 86.68%253.09B |
| -Depreciation and amortization | 44.06%205.16B | -19.16%131.64B | -1.36%643.23B | 39.94%203.08B | -46.69%134.91B | -40.72%142.41B | 25.81%162.83B | 20.22%652.12B | 8.92%145.11B | 86.68%253.09B |
| Other operating expenses | 288.16%43.55B | -88.70%6.03B | 5.67%37.05B | -12.33%-112.17B | -0.22%84.61B | -84.35%11.22B | 86.29%53.38B | 55.70%35.06B | -12.90%-99.86B | 106.40%84.8B |
| Operating profit | -62.55%69B | 10.96%184.57B | 32.74%486.06B | -51.74%68.54B | 209.60%66.94B | 473.41%184.25B | -1.33%166.33B | -37.71%366.17B | -23.59%142.02B | -141.56%-61.08B |
| Net non-operating interest income /expenses | 39.78%-38.74B | -15.12%-33.4B | -0.86%-141.67B | 29.98%-9.73B | 13.83%-38.58B | -32.21%-64.34B | 12.40%-29.01B | -13.84%-140.46B | 73.14%-13.9B | -17.62%-44.78B |
| Non-operating interest income | 978.62%44.4B | 140.43%73.76B | 73.90%19.64B | 76.54%-8.17B | -132.07%-6.99B | -56.02%4.12B | 15.96%30.68B | 105.03%11.29B | 29.85%-34.81B | -47.72%21.79B |
| Non-operating interest expense | 21.45%83.14B | 79.52%107.16B | 14.87%137.31B | 57.78%-22.43B | -52.54%31.6B | 17.98%68.45B | 0.19%59.69B | 2.19%119.54B | -442.57%-53.13B | -16.53%66.57B |
| Total other finance cost | ---- | ---- | -25.53%24B | ---- | ---- | ---- | ---- | 170.31%32.22B | ---- | ---- |
| Other net income /expenses | -288.60%-2.08B | 24.72%-536M | 2.08%-169.31B | 5.43%-166.11B | -101.17%-1.95B | -126.42%-535M | -70.33%-712M | -93.55%-172.91B | -103.75%-175.64B | 9,557.89%167.12B |
| Gain on sale of security | ---- | ---- | 183.25%7.6B | ---- | ---- | ---- | ---- | -241.82%-9.13B | ---- | ---- |
| Special income /charges | ---- | ---- | -1.57%-172.92B | ---- | ---- | ---- | ---- | -55.39%-170.25B | ---- | ---- |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | 24.89%127.53B | ---- | ---- | ---- | ---- | 61.51%102.12B | ---- | ---- |
| -Less:Other special charges | ---- | ---- | -40.72%37.57B | ---- | ---- | ---- | ---- | 157.52%63.37B | ---- | ---- |
| -Less:Write off | ---- | ---- | 44.34%18.38B | ---- | ---- | ---- | ---- | -58.42%12.74B | ---- | ---- |
| -Gain on sale of business | ---- | ---- | 30.23%10.2B | ---- | ---- | ---- | ---- | 15.04%7.83B | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | 152.08%363M | ---- | ---- | ---- | ---- | -93.12%144M | ---- | ---- |
| Income before tax | -76.40%28.17B | 10.27%150.63B | 231.66%175.08B | -125.79%-107.3B | -56.89%26.41B | 224.37%119.37B | 1.16%136.6B | -85.93%52.79B | -199.18%-47.52B | -42.83%61.26B |
| Income tax | 46.35%39.9B | -36.20%26.35B | 173.23%66.94B | 90.57%-4.2B | 105.78%2.57B | 156.79%27.27B | -9.47%41.3B | -257.46%-91.41B | -365.38%-44.53B | -270.92%-44.5B |
| Net income | -112.73%-11.73B | 30.41%124.28B | -25.00%108.14B | -3,343.49%-103.1B | -77.46%23.84B | 292.01%92.11B | 6.59%95.3B | -54.52%144.2B | -109.62%-2.99B | -11.24%105.76B |
| Net income continuous operations | -112.73%-11.73B | 30.41%124.28B | -25.00%108.14B | -3,343.49%-103.1B | -77.46%23.84B | 292.00%92.11B | 6.59%95.3B | -54.52%144.2B | -109.62%-2.99B | -11.24%105.76B |
| Noncontrolling interests | 18.03%72M | -29.41%36M | 65.38%215M | 137.50%57M | 31.43%46M | 3.39%61M | 363.64%51M | 519.05%130M | 1,100.00%24M | 59.09%35M |
| Net income attributable to the company | -112.82%-11.8B | 30.44%124.24B | -25.08%107.93B | -3,317.99%-103.16B | -77.50%23.79B | 291.64%92.05B | 6.55%95.25B | -54.56%144.07B | -109.69%-3.02B | -11.25%105.72B |
| Net income attributable to common stockholders | -112.82%-11.8B | 30.44%124.24B | -25.08%107.93B | -3,317.99%-103.16B | -77.50%23.79B | 291.64%92.05B | 6.55%95.25B | -54.56%144.07B | -109.69%-3.02B | -11.25%105.72B |
| Diluted earnings per share | -113.47%-7.83 | 30.79%79.4 | -25.77%68.36 | -3,151.24%-65.35 | -78.01%14.86 | 289.50%58.14 | 5.56%60.71 | -54.92%92.09 | -110.07%-2.01 | -11.80%67.59 |
| Basic earnings per share | -113.70%-7.83 | 30.51%78.23 | -26.25%67.23 | -3,151.24%-65.35 | -78.20%14.58 | 286.34%57.17 | 4.94%59.94 | -54.86%91.16 | -110.42%-2.01 | -11.84%66.88 |
| Dividend per share | 2.04%100 | --0 | 4.26%196 | 4.26%98 | --0 | 4.26%98 | --0 | 4.44%188 | 4.44%94 | --0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"